Medicine Description mabthera 100mg
Mabthera 100mg Vial is a medication that contains rituximab, a chimeric monoclonal antibody specifically designed to target the CD20 antigen present on the surface of B cells. By binding to CD20, rituximab initiates a series of immune responses, including antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), ultimately leading to the depletion of B cells. This targeted action is crucial in managing conditions where B cells are pathologically active, such as certain lymphomas and autoimmune diseases, thus reducing inflammation and disease progression.
Indications and Uses of Mabthera 100mg Vial
- Non-Hodgkin lymphoma
- Chronic lymphocytic leukemia (CLL)
- Rheumatoid arthritis (as part of a combination therapy)
- Granulomatosis with polyangiitis
- Microscopic polyangiitis
Side Effects of Mabthera 100mg Vial
- Infusion-related reactions
- Fever
- Fatigue
- Low blood cell counts (e.g., neutropenia, thrombocytopenia)
- Infections
- Severe skin reactions
- Cardiovascular complications
Storage and Handling
Mabthera 100mg Vial should be stored in a refrigerator at temperatures between 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze. Once prepared for infusion, the solution should be used immediately or can be stored at room temperature for a limited time, as determined by a healthcare professional.
Patient Advice and Precautions
Patients should be monitored for infusion-related reactions during administration. It is crucial to inform healthcare providers about any history of heart problems or infections prior to treatment. Regular blood tests may be required to monitor blood cell levels. Avoid live vaccines during therapy and consult with a healthcare professional for any vaccinations or medications.